The Florida Department of Health issued emergency rules Wednesday that will block thousands of Floridians from accessing their HIV medication. Starting Sunday, the state will cut its subsidies for the ...

The program provides access to medication for low-income, HIV-positive Floridians either by directly giving them prescription medications or by paying for insurance coverage that includes HIV ...

IMAGE DISTRIBUTED FOR AIDS HEALTHCARE FOUNDATION - Florida State Senator Shevrin Jones, stands with over 100 healthcare advocates from across the state, for the Fight for Our Lives Rally, on Tuesday, ...

Jonathan Appelbaum does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

More than 128,000 Floridians are living with HIV. The state has the second-highest rate of new HIV diagnoses after Georgia, with approximately 4,500 new diagnoses in 2023, the most recent year for ...

After the first attempt at a 340B rebate pilot stalled in court in December, the Health Resources and Services Administration is looking into a pilot that would require 340B program participants to ...

Aaron Bean hosted a panel on Capitol Hill that touched on the program's reach to Jacksonville area hospitals. But Karyn Schwartz, Senior Vice President of Policy and Research Development for PhRMA, ...

TALLAHASSEE, Fla. (WCTV/Gray Florida Capital Bureau) - The Florida Department of Health has stepped back from planned changes to a program that provides HIV medication to thousands of Floridians, ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Dr. Marty Makary, commissioner of the Food and ...

The DeSantis administration announced Tuesday that it’s developing three new rules meant to curb spending in a federally funded program that provides benefits to people with HIV and AIDS. The ...

WASHINGTON (AP) — A Democratic lawmaker raised new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs, including whether senior officials ...